NEW YORK, September 12, 2013 /PRNewswire/ --
Elsevier, a world-leading provider of scientific, technical and medical information products and services, is pleased to announce the launch of a new open access research publication - Journal of Clinical and Translational Endocrinology (JCTE).
The scope of this new journal is patient-oriented research in a variety of disciplines in endocrinology, including diabetes, metabolic bone disease and osteoporosis, thyroid disease, pituitary and lipid disorders. Areas of high priority include novel pilot/proof-of-concept clinical trials in humans and basic science research involving human specimens.
Dr. Vin Tangpricha from Emory University, Atlanta, Editor-in-Chief of the journal, said, " Journal of Clinical and Translational Endocrinology will provide authors a unique home for manuscripts focused on patient-oriented endocrinology research that translates basic science research to clinical applications for patients with endocrine diseases. As a practicing clinician and a researcher in endocrinology, I understand the importance of strengthening the relationship between the clinical and basic sciences. We look forward to providing the scientific community with high-yield content that addresses the needs of readers and investigators interested in translational research of endocrine diseases."Andrew Miller, Executive Publisher at Elsevier, added, " Journal of Clinical and Translational Endocrinology will offer the research community a unique and dynamic blend of tradition and innovation: editorial review from an expert team of researchers together with our publishing and dissemination systems, involving innovative, digital approaches. Elsevier is very pleased to launch JCTE and work with Dr. Tangpricha and the journal editors to serve the needs of endocrinologists internationally." For more information or to submit an article, go to: www.JCTEjournal.com. The journal is ready to accept submissions. About the Edi to r-in-Chief: Dr. Vin Tangpricha, MD, PhD Dr. Vin Tangpricha is an Associate Professor of Medicine at Emory University School of Medicine in the Division of Endocrinology, Metabolism and Lipids. He received his M.D. at Tufts University and completed his internal medicine residency and endocrinology fellowship at Boston University Medical Center. He completed a PhD in Molecular Medicine on the topic of colon cancer and vitamin D. Dr. Tangpricha has published a number of manuscripts investigating the role of vitamin D in patients with chronic kidney disease, cystic fibrosis, and infections including HIV and TB. He is currently conducting a number of clinical trials to translate findings from the bench that suggest that vitamin D may play an important role in improving outcomes in patients with infections. About Open Access Publishing at Elsevier
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV